Atara Biotherapeutics (ATRA) Gross Margin (2022 - 2026)
Atara Biotherapeutics' Gross Margin came in at 69.68% for Q2 2026, down 27.17 percentage points from 96.85% a year earlier and down 6.29 percentage points from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Gross Margin (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Atara Biotherapeutics reported Gross Margin of 91.38%, up 10.14 percentage points year-over-year; for FY2025, it was 82.44%, down 1.27 percentage points from FY2024.
- Gross Margin carries a three-year change of -17.56 percentage points (FY2022 to FY2025).
- Going back by year, Gross Margin was 83.71% in FY2024 (+87.36 pp), -3.65% in FY2023 (-103.65 pp) and 100.00% in FY2022.
- The Q2 2026 figure represents the lowest quarterly Gross Margin since Q4 2023.
- Year-over-year, Gross Margin increased in five of the last eight quarters, with an average year-over-year change of +19.48 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2024 (a gain of 286.35 percentage points), and the weakest in Q2 2023 (a drop of 302.51 percentage points).
- Business Quant data shows ATRA's Gross Margin at 75.97% (Q1 2026), 93.48% (Q4 2025) and 96.67% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 69.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.68% |
| Mar 31, 2026 | 75.97% |
| Dec 31, 2025 | 93.48% |
| Sep 30, 2025 | 96.67% |
| Jun 30, 2025 | 96.85% |
| Mar 31, 2025 | 79.18% |
| Dec 31, 2024 | 79.25% |
| Sep 30, 2024 | 81.08% |
| Jun 30, 2024 | 83.84% |
| Mar 31, 2024 | 92.74% |
| Dec 31, 2023 | 25.68% |
| Sep 30, 2023 | -22.31% |
| Jun 30, 2023 | -202.51% |
| Mar 31, 2023 | 82.38% |
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 100.00% |
API Access
Atara Biotherapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();